Eyelash enhancement properties of topical dechloro ethylcloprostenolamide
Authors:
- Susan LinSLSusan Lin
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Journal of Cosmetic and Laser Therapy
- Vol. 10 (2) , 110-113
Abstract
To assess subjective reports by users of MD Lash Factor(TM) that it improved the appearance of their eyelashes, especially in length. A randomized, double-blind, clinical trial was performed on 34 healthy volunteers who were randomly assigned to one of three different treatment groups of varying concentrations of the key ingredient (dechloro ethylcloprostenolamide, a novel synthetic topical prostaglandin analogue) and a placebo group. All treatment groups demonstrated a statistically significant increase in eyelash length after 4 weeks of daily use. Group A: 1.69 mm, Group B: 1.94 mm, Group D: 1.44 mm, and Group C (placebo): 0.63 mm. There were no complications. Fifteen patients reported minimal initial transient irritation. Subjective reports by users of improved appearance in their eyelashes were confirmed. Use of dechloro ethylcloprostenolamide had minimal side effects.Keywords
This publication has 11 references indexed in Scilit:
- Clinical Course of Bimatoprost-Induced Periocular Skin Changes in CaucasiansOphthalmology, 2006
- The Comparison of Eyelash Lengthening Effect of Latanoprost Therapy in Adults and ChildrenEuropean Journal of Ophthalmology, 2006
- Bimatoprost-Induced Periocular Skin HyperpigmentationArchives of Ophthalmology (1950), 2005
- Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%Ophthalmology, 2004
- A Prospective Study of Iridial Pigmentation and Eyelash Changes Due to Ophthalmic Treatment with LatanoprostJapanese Journal of Ophthalmology, 2004
- Cutaneous latanoprost in the treatment of alopecia areataEye, 2003
- Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertensionAdvances in Therapy, 2003
- Quantitative analysis of eyelash lengthening following topical latanoprost therapyCanadian Journal of Ophthalmology, 2002
- Prostaglandin-Induced Hair GrowthSurvey of Ophthalmology, 2002
- Eyelash Formation Secondary to Latanoprost Treatment in a Patient With AlopeciaArchives of Ophthalmology (1950), 2000